Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Assessment of effectiveness of a COVID-adapted diagnostic pathway for colorectal cancer to mitigate the adverse impact on investigation and referrals

Janice Miller, Yasuko Maeda, Stephanie Au, Frances Gunn, Lorna Porteous, Rebecca Pattenden, Peter MacLean, Colin L Noble, Stephen Glancy, Malcolm G Dunlop, Farhat V N Din
doi: https://doi.org/10.1101/2020.11.23.20236778
Janice Miller
1Department of Colorectal Surgery, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
2Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, EH16 4SA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasuko Maeda
1Department of Colorectal Surgery, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
2Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, EH16 4SA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Au
1Department of Colorectal Surgery, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frances Gunn
1Department of Colorectal Surgery, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorna Porteous
3Lead GP for cancer and palliative care, NHS Lothian, Edinburgh, EH1 3EG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca Pattenden
4Department of Biochemistry, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter MacLean
5Department of Radiology, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colin L Noble
6Department of Gastroenterology, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Glancy
5Department of Radiology, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malcolm G Dunlop
1Department of Colorectal Surgery, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
2Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, EH16 4SA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farhat V N Din
1Department of Colorectal Surgery, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU
2Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, EH16 4SA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Farhat.Din@igmm.ed.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives The Coronavirus-19 (COVID-19) pandemic continues to impose formidable challenges on healthcare services. The dramatic curtailment of endoscopy and CT colonography capacity has adversely impacted on timely diagnosis of colorectal cancer (CRC). We describe a COVID-adapted pathway rapidly implemented to mitigate risk and maximise cancer diagnosis in patients referred with symptoms of suspected CRC during the pandemic.

Design The “COVID-adapted pathway” integrated multiple quantitative faecal immunochemical tests (qFIT), to enrich for significant colorectal disease. CT with oral contrast was used to detect gross pathology. Patients reporting ‘high-risk’ symptoms were triaged to qFIT+CT and the remainder underwent initial qFIT. Prospective data collection comprised referral category, symptoms, blood results, medical history, time to first test, qFIT and CT results.

Setting Tertiary colorectal unit which manages over 500 cancer patients annually.

Participants All patients referred as ‘urgent suspicious of cancer’ (USOC) were included. Overall 422 patients (median age 64 years, 220 females) were triaged using this pathway.

Main outcome measures Outcomes comprised cancer detection frequency.

Results Compared to the same time period (1st April – 31st May) in 2017-2019, we observed a 43% reduction in primary care referrals with suspected CRC (1071 referrals expected reducing to 609). Overall 422 patients (median age 64 years, 220 females) were triaged using this pathway. Most (84·6%) were referred as USOC. Of the 422 patients, 202 (47·9%) were triaged to CT and qFIT, 211 (50·0%) to qFIT only, eight (1·9%) to outpatient clinic, and one to colonoscopy. Fifteen (3·6%) declined investigation and seven (1·7%) were deemed unfit. We detected 13 cancers (3·1%); similar to the mean cancer detection rate from all referrals in 2017-2019 (3·3%).

Conclusions The response to the COVID-19 pandemic resulted in a marked reduction in referrals and cessation of key diagnostic services. Although this COVID-adapted pathway mitigated the adverse effects on diagnostic capacity, the overall reduction in expected diagnoses is very substantial. It is clear that the adverse impact of measures taken to constrain the pandemic will lead to many undetected cancers due to the decrease in referrals.

Trial registration Not applicable

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

Not applicable. Study is reporting data as part of routine clinical care.

Clinical Protocols

https://doi.org/10.1002/bjs.11798

Funding Statement

This pathway was funded by NHS Lothian and the Scottish Government as part of routine clinical care.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

NHS Lothian

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

De-identified data is available from the corresponding author on request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted November 24, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Assessment of effectiveness of a COVID-adapted diagnostic pathway for colorectal cancer to mitigate the adverse impact on investigation and referrals
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Assessment of effectiveness of a COVID-adapted diagnostic pathway for colorectal cancer to mitigate the adverse impact on investigation and referrals
Janice Miller, Yasuko Maeda, Stephanie Au, Frances Gunn, Lorna Porteous, Rebecca Pattenden, Peter MacLean, Colin L Noble, Stephen Glancy, Malcolm G Dunlop, Farhat V N Din
medRxiv 2020.11.23.20236778; doi: https://doi.org/10.1101/2020.11.23.20236778
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Assessment of effectiveness of a COVID-adapted diagnostic pathway for colorectal cancer to mitigate the adverse impact on investigation and referrals
Janice Miller, Yasuko Maeda, Stephanie Au, Frances Gunn, Lorna Porteous, Rebecca Pattenden, Peter MacLean, Colin L Noble, Stephen Glancy, Malcolm G Dunlop, Farhat V N Din
medRxiv 2020.11.23.20236778; doi: https://doi.org/10.1101/2020.11.23.20236778

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (143)
  • Anesthesia (47)
  • Cardiovascular Medicine (419)
  • Dentistry and Oral Medicine (72)
  • Dermatology (49)
  • Emergency Medicine (147)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (172)
  • Epidemiology (4904)
  • Forensic Medicine (3)
  • Gastroenterology (185)
  • Genetic and Genomic Medicine (689)
  • Geriatric Medicine (72)
  • Health Economics (193)
  • Health Informatics (636)
  • Health Policy (322)
  • Health Systems and Quality Improvement (209)
  • Hematology (85)
  • HIV/AIDS (157)
  • Infectious Diseases (except HIV/AIDS) (5405)
  • Intensive Care and Critical Care Medicine (333)
  • Medical Education (96)
  • Medical Ethics (24)
  • Nephrology (77)
  • Neurology (692)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (128)
  • Occupational and Environmental Health (211)
  • Oncology (447)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (91)
  • Pain Medicine (37)
  • Palliative Medicine (18)
  • Pathology (131)
  • Pediatrics (201)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (88)
  • Psychiatry and Clinical Psychology (787)
  • Public and Global Health (1831)
  • Radiology and Imaging (328)
  • Rehabilitation Medicine and Physical Therapy (142)
  • Respiratory Medicine (257)
  • Rheumatology (87)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (63)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)